Results 11 to 20 of about 641,953 (241)

Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms [PDF]

BMC Cancer, 2023
Purpose Programmed death-1 (PD-1) and T cell immunoglobulin and mucin-domain-containing molecule 3(Tim-3) may be used as the biomarkers for the therapy in patients with peritoneal neoplasms.
Huihui Hu, Jin Zhao, Judong Yuan, Man Zhang   +3 more
doaj   +3 more sources

Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. [PDF]

PLoS ONE, 2012
BackgroundPower morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum.
Michael A Seidman, Titilope Oduyebo, Michael G Muto, Christopher P Crum, Marisa R Nucci, Bradley J Quade   +5 more
doaj   +10 more sources

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms

Annals of Surgical Oncology, 2020
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of appendiceal neoplasms specifically related to the management of peritoneal surface malignancies. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative ...
C. Group
semanticscholar   +8 more sources

Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma

Taiwanese Journal of Obstetrics & Gynecology, 2014
In the previous issue of this journal (Volume 51, Number 3, pp. 463e464), Wang and colleagues [1] published a very interesting research letter entitled “Peritoneal papillary serous cystadenocarcinoma at a previous laparoscopic trocar site”.
Chiung-Ru Lai
doaj   +4 more sources

Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms [PDF]

Journal of Pathology and Translational Medicine, 2021
Although the understanding of appendiceal mucinous neoplasms (AMNs) and their relationship with disseminated peritoneal mucinous disease have advanced, the diagnosis, classification, and treatment of AMNs are still confusing for pathologists and ...
Dong-Wook Kang, Baek-hui Kim, Joon Mee Kim, Jihun Kim, Hee Jin Chang, Mee Soo Chang, Jin-Hee Sohn, Mee-Yon Cho, So-Young Jin, Hee Kyung Chang, Hye Seung Han, Jung Yeon Kim, Hee Sung Kim, Do Youn Park, Ha Young Park, So Jeong Lee, Wonae Lee, Hye Seung Lee, Yoo Na Kang, Younghee Choi, The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists   +20 more
doaj   +2 more sources

CT imaging review of uncommon peritoneal-based neoplasms: beyond carcinomatosis

The British Journal of Radiology, 2021
Pathologic involvement of the peritoneum can result from a wide variety of conditions, including both neoplastic and non-neoplastic entities. Neoplastic involvement of the peritoneal ligaments, mesenteries, and spaces from malignant spread of epithelial cancers, termed peritoneal carcinomatosis, is frequently encountered at CT evaluation.
Perry J, Pickhardt, Alberto A, Perez, Mohab M, Elmohr, Khaled M, Elsayes   +3 more
openaire   +4 more sources

Cytokines in peritoneal fluid of ovarian neoplasms

Journal of Obstetrics and Gynaecology, 2019
The aim of this study was to evaluate cytokine levels (IL-2, IL-8, TNF-α, IL-5, IL-6 and IL-10) in the peritoneal fluid in non-neoplastic tumours, benign ovarian neoplasms and malignant ovarian neoplasms. Peritoneal fluid or ascites was collected from 117 patients with neoplastic and non-neoplastic ovarian tumours.
Cid Almeida, de Lima, Isac Souza, Silva Rodrigues, Agrimaldo, Martins-Filho, Douglas, Côbo Micheli, Beatriz, Martins Tavares-Murta, Eddie Fernando, Candido Murta, Rosekeila, Simões Nomelini   +6 more
openaire   +3 more sources

The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms

Cancer, 2020
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists ...
C. Group
semanticscholar   +5 more sources

Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms [PDF]

Annals of Surgical Oncology, 2012
Peritoneal carcinomatosis (PC) in the setting of mucinous appendiceal neoplasms is characterized by the intraperitoneal accumulation of mucinous ascites and mucin-secreting epithelial cells that leads to progressive compression of intra-abdominal organs, morbidity, and eventual death.
Frances, Austin, Arun, Mavanur, Magesh, Sathaiah, Jennifer, Steel, Diana, Lenzner, Lekshmi, Ramalingam, Matthew, Holtzman, Steven, Ahrendt, James, Pingpank, Herbert J, Zeh, David L, Bartlett, Haroon A, Choudry   +11 more
openaire   +3 more sources

Extent of Disease on Visceral Peritoneal Surfaces of Mucinous Appendiceal Neoplasms Controls Survival

Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2022
Objective: To determine causes of treatment failure of low-grade appendiceal mucinous neoplasms (LAMN). Background: For 3 decades, LAMN have been treated by cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy.
P. Sugarbaker, D. Chang
semanticscholar   +1 more source